Globe Life initiated with a Buy at Truist

Truist initiated coverage of Globe Life (GL) with a Buy rating and $150 price target The firm says the company’s diversified model that supports steady returns while the shares trade at a discount to peers. The stock can now be bought at a discount valuation because of a “misguided” short report and short-term volatility in medical utilization, the analyst tells investors in a research note.